Mylo raises $17 million funding led by W Health Ventures, ITC & Endiya Partners

Mylo, a platform for expecting and new mothers, has announced a funding round of $17 million led by W Health Ventures, a US-based digital health investor, ITC and Endiya Partners.

Govt panel suggests EUA for Biological E's Corbevax for 5 to 11 years

An Expert panel of India’s central drug authority has suggested granting emergency use authorisation for Biological E’s COVID-19 vaccine Corbevax for children in the five to 11 years age group with certain conditions, official sources...

Funneling Credit to Pharmaceutical Industry

Innovative credit products that include funds against Intellectual property rights are being examined by the government with an aim to increase the credit flow to the pharmaceuticals industry.

Even Healthcare Makes Preventive Care Affordable & provides unlimited OPD to Customers

Even Healthcare, a health-tech firm and healthcare provider, under its 'Even Plus' and 'Even Lite' plans, offers its customers unlimited outpatient department (OPD) which includes doctor consultations and diagnostics...

Ramsay Health Care gets $14.8 bln bid from KKR-led consortium

Ramsay Health Care Ltd, Australia's largest private hospital operator, said on Wednesday it received a A$20.05 billion ($14.80 billion) indicative takeover offer from a consortium led by private equity giant KKR & Co...

NPPA to set up a digital platform to track availability of essential drugs across the country

The National Pharmaceutical Pricing Authority has initiated efforts to track the availability of essential drugs across the countryby creating a national level digital platform in which the stock positions could be updated by the stakeholders....

Cigna's Evernorth unit partners with Kaiser Permanente to gain access to doctors while travelling

Health insurer Cigna Corp's Evernorth unit would partner with Kaiser Permanente to help patients enrolled in some its rival's health plans gain access to doctors while traveling.

Alembic receives USFDA authorization to market generic drug for heart failure

Alembic Pharmaceuticals Limited today announced that it has received tentative approval from the US Food & Drug Administration for its Abbreviated New Drug Application (ANDA) for Ivabradine tablets, 5 mg and 7.5 mg.

Sanofi India assigns Rodolfo Hrosz as MD

Sanofi India Limited told that its Board of Directors has appointed Rodolfo Hrosz as the Company’s new Managing Director with effect from June 1, 2022, subject to regulatory approvals. He will transition from being Sanofi’s General Manager...

South Korea approves phase 3 clinical trial of breast cancer treatment 'Tucatinib'

Phase 3 clinical trials of new breast cancer treatment approved in the U.S. and Europe will be conducted in Korea.

© 2025 India Pharma Outlook. All Rights Reserved.